The scientific advisers IOCOB are: 

• Prof. dr HP Bertram, pharmacologist, University of Witten, Germany
• Prof. dr DIAnne Bradford, Department of Psychiatry, Morehouse School of Medicine, Atlanta, USA
• Prof. dr J. van der Greef, Scientific Director TNO Systems Biology
• Prof. dr I. Hindmarch, psychologist, University of Surrey, UK
• Prof. dr M. Hunink, clinical epidemiologist, University of Rotterdam and Harvard University, USA
• Prof. dr JJ Jolles, neuropsycholoog, University of Maastricht
• Prof. dr J. de Jong, psychiatrist, VU Amsterdam, Boston University School of Medicine, USA
• Prof. dr E. van Leeuwen, medical philosopher, University of Nijmegen
• Prof. dr G. Lipkin, dermatologist, New York School of Medicine, USA
• Prof. dr E. Lindeman, revalidatiearts, University of Utrecht
• Prof. dr JJ Rasker, reumatoloog, University of Twente
• Prof. dr WP Vandertop, neurosurgeon, VU Amsterdam & University of Amsterdam
• Prof. dr FJ Verheijen, EM. Professor comparative physiology, Utrecht

The cooperation of IOCOB scientific advisers and is characterized by the following events

• The scientific adviser gives advice on the methodology and / or feasibility of the administration of IOCOB presented research in the field of the effectiveness of CAM therapeutic linterventions.
• The consultant commented on proposals by the board of the foundation on how one can apply the principles of "evidence-based medicine ‘on the areas of IOCOB.
• The consultant has no responsibility for the selection of research projects by the board of the Foundation or the implementation of the project
• The board is responsible for the content of the website of the foundation
•  Also the board will at least once a year report to the consultants on relevant developments within IOCOB in the field of which the advice was given.

The opinions of the advisers are confidential and the Foundation will not disclose the advice without written permission. Also the board will abstain from the (implicit) use of the name of a consultant in communications with third parties, with the exception of actual announcements about what is stated above.